Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Wednesday February 13, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Richard Finn, MD, Professor of Medicine at the Geffen School of Medicine, UCLA, discuss hepatocellular carcinoma (HCC) clinical highlights from ASCO GI 2019

Featured Videos

Robert Rifkin, MD, FACP, regarding the role of proteasome inhibitors in maintenance therapy for MM

Nikhil Munshi, MD, tells us about the outcomes of the CARTITUDE-1 study from ASH 2019

Nevena Damjanov, MD, on impressions of the study of cabozantinib with in HCC patients